Home LiteratureArticle Details
PMID: 9703464 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

Journal of medicinal chemistry ·Vol. 41 ·No. 17 ·1998-08-13 ·Pages 3186-201

Li AH, Moro S, Melman N, Ji XD, Jacobson KA

Abstract

The structure-activity relationships of 6-phenyl-1,4-dihydropyridine derivatives as selective antagonists at human A3 adenosine receptors have been explored (Jiang et al. J. Med. Chem. 1997, 39, 4667-4675). In the present study, related pyridine derivatives have been synthesized and tested for affinity at adenosine receptors in radioligand binding assays. Ki values in the nanomolar range were observed for certain 3,5-diacyl-2,4-dialkyl-6-phenylpyridine derivatives in displacement of [125I]AB-MECA (N6-(4-amino-3-iodobenzyl)-5'-N-methylcarbamoyladenosine) at recombinant human A3 adenosine receptors. Selectivity for A3 adenosine receptors was determined vs radioligand binding at rat brain A1 and A2A receptors. Structure-activity relationships at various positions of the pyridine ring (the 3- and 5-acyl substituents and the 2- and 4-alkyl substituents) were probed. A 4-phenylethynyl group did not enhance A3 selectivity of pyridine derivatives, as it did for the 4-substituted dihydropyridines. At the 2- and 4-positions ethyl was favored over methyl. Also, unlike the dihydropyridines, a thioester group at the 3-position was favored over an ester for affinity at A3 adenosine receptors, and a 5-position benzyl ester decreased affinity. Small cycloalkyl groups at the 6-position of 4-phenylethynyl-1,4-dihydropyridines were favorable for high affinity at human A3 adenosine receptors, while in the pyridine series a 6-cyclopentyl group decreased affinity. 5-Ethyl 2, 4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate , 38, was highly potent at human A3 receptors, with a Ki value of 20 nM. A 4-propyl derivative, 39b, was selective and highly potent at both human and rat A3 receptors, with Ki values of 18.9 and 113 nM, respectively. A 6-(3-chlorophenyl) derivative, 44, displayed a Ki value of 7.94 nM at human A3 receptors and selectivity of 5200-fold. Molecular modeling, based on the steric and electrostatic alignment (SEAL) method, defined common pharmacophore elements for pyridine and dihydropyridine structures, e.g., the two ester groups and the 6-phenyl group. Moreover, a relationship between affinity and hydrophobicity was found for the pyridines.

MeSH Terms
Adenosine/analogs & derivatives,metabolism Animals Binding, Competitive Brain/metabolism Dihydropyridines/chemical synthesis,chemistry,pharmacology Drug Design Humans Iodine Radioisotopes Kinetics Models, Molecular Molecular Conformation Molecular Structure Purinergic P1 Receptor Antagonists Pyridines/chemical synthesis,chemistry,pharmacology Radioligand Assay Rats Receptor, Adenosine A2A Receptor, Adenosine A3 Recombinant Proteins/antagonists & inhibitors Structure-Activity Relationship
Chemicals
Dihydropyridines Iodine Radioisotopes Purinergic P1 Receptor Antagonists Pyridines Receptor, Adenosine A2A Receptor, Adenosine A3 Recombinant Proteins N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide Adenosine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Li A H
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, USA.
Moro S
Melman N
Ji X D
Jacobson K A
References (23)
23 references, click to expand
  1. 6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
    J Med Chem. 1996 Nov 8;39(23):4667-75 PMID: 8917655
  2. Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.
    J Clin Invest. 1996 Oct 15;98(8):1773-9 PMID: 8878427
  3. Plasma and urinary metabolites of efonidipine hydrochloride in man.
    Xenobiotica. 1996 Feb;26(2):229-39 PMID: 8868006
  4. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
    J Med Chem. 1996 Oct 11;39(21):4142-8 PMID: 8863790
  5. Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.
    J Med Chem. 1996 Jul 19;39(15):2980-9 PMID: 8709132
  6. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.
    J Med Chem. 1996 Jun 7;39(12):2293-301 PMID: 8691424
  7. Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate).
    J Med Chem. 1996 Mar 15;39(6):1253-61 PMID: 8632432
  8. Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen- and Ca(2+)-ionophore-induced secretion in a rat mast cell line.
    J Pharmacol Exp Ther. 1996 Feb;276(2):837-45 PMID: 8632357
  9. Adenosine A3 receptor stimulation and cerebral ischemia.
    Eur J Pharmacol. 1994 Sep 22;263(1-2):59-67 PMID: 7821362
  10. 125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    Mol Pharmacol. 1994 May;45(5):978-82 PMID: 8190112
  11. Adenosine A3 receptors in mast cells.
    Trends Pharmacol Sci. 1994 Jan;15(1):13-4 PMID: 8140652
  12. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.
    J Med Chem. 1994 Mar 4;37(5):636-46 PMID: 8126704
  13. Molecular cloning and characterization of the human A3 adenosine receptor.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9 PMID: 8234299
  14. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.
    J Biol Chem. 1993 Aug 15;268(23):16887-90 PMID: 8349579
  15. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432-6 PMID: 1323836
  16. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    J Pharmacol Exp Ther. 1989 Dec;251(3):888-93 PMID: 2600819
  17. Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.
    Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):179-87 PMID: 6253840
  18. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
    Biochem Pharmacol. 1973 Dec 1;22(23):3099-108 PMID: 4202581
  19. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.
    Neuropharmacology. 1997 Sep;36(9):1157-65 PMID: 9364471
  20. Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.
    J Neurosci. 1997 Jan 15;17(2):607-14 PMID: 8987783
  21. Adenosine A3 receptor stimulation inhibits migration of human eosinophils.
    J Leukoc Biol. 1997 Oct;62(4):465-8 PMID: 9335316
  22. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    J Med Chem. 1997 Aug 1;40(16):2596-608 PMID: 9258367
  23. Adenosine A3 receptors: novel ligands and paradoxical effects.
    Trends Pharmacol Sci. 1998 May;19(5):184-91 PMID: 9652191
Article Info
Journal
Journal of medicinal chemistry
Abbr.
J Med Chem
ISSN
0022-2623
Published
1998-08-13
Pages
3186-201
Language
English
Region
United States
NLM ID
9716531
PMCID
PMC3474377
Subset
IM
Grants
Intramural NIH HHS · Z01 DK031117-20 · United States
Intramural NIH HHS · Z99 DK999999 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]